Literature DB >> 17617183

Host and bacterial determinants of initial severity and outcome of Escherichia coli sepsis.

F Jauréguy1, E Carbonnelle, S Bonacorsi, C Clec'h, P Casassus, E Bingen, B Picard, X Nassif, O Lortholary.   

Abstract

A 1-year prospective cohort study of all episodes of Escherichia coli bacteraemia in two French university hospitals was conducted to assess simultaneously the influence of host and bacterial determinants on the initial severity and outcome of E. coli sepsis. Clinical data (community-acquired/nosocomial infection, immune status, underlying disease, primary source of infection, severity sepsis scoring and outcome), phylogenetic groups (A, B1, D and B2), nine virulence factors (VFs) (papC, papGII, papGIII, sfa/foc, hlyC, cnf1, iucC, fyuA and iroN) and the antibiotic susceptibility of isolates were investigated. All VFs except iucC were significantly more prevalent (p <0.05) among the B2 group isolates. The non-B2 isolates were more frequently resistant to antibiotics than were B2 isolates (p <0.05). There were significantly more B2 isolates from immunocompetent than from immunocompromised patients (p <0.05). No bacterial or host determinants influenced the initial severity of sepsis. Multivariate analysis revealed that the presence of papGIII, septic shock at baseline and a non-urinary tract origin of sepsis were associated independently with a fatal outcome (p 0.04, <0.0001 and 0.04, respectively). A factorial analysis of correspondence allowed two populations of isolates to be distinguished: those belonging to the B2 group were associated more frequently with susceptibility to antibiotics, community-acquired infection, a urinary tract origin and immunocompetent hosts; those belonging to the A, B1 or D groups were associated more frequently with resistance to antibiotics, a nosocomial origin, a non-urinary tract source and immunocompromised hosts. Although no influence of host or bacterial determinants on the initial severity of sepsis was detected, bacterial and host determinants both influenced the outcome of E. coli sepsis significantly.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17617183     DOI: 10.1111/j.1469-0691.2007.01775.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  33 in total

1.  Role of K1 capsule antigen in cirrhotic patients with Escherichia coli spontaneous bacterial peritonitis in southern Taiwan.

Authors:  M C Wang; W H Lin; C C Tseng; A B Wu; C H Teng; J J Yan; J J Wu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-10-08       Impact factor: 3.267

2.  Cyclomodulins in urosepsis strains of Escherichia coli.

Authors:  Damien Dubois; Julien Delmas; Anne Cady; Frédéric Robin; Adeline Sivignon; Eric Oswald; Richard Bonnet
Journal:  J Clin Microbiol       Date:  2010-04-07       Impact factor: 5.948

3.  Host factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia.

Authors:  Agnès Lefort; Xavière Panhard; Olivier Clermont; Paul-Louis Woerther; Catherine Branger; France Mentré; Bruno Fantin; Michel Wolff; Erick Denamur
Journal:  J Clin Microbiol       Date:  2010-12-22       Impact factor: 5.948

4.  High rate of fecal carriage of extended-spectrum-β-lactamase-producing Escherichia coli in healthy children in Gipuzkoa, northern Spain.

Authors:  María Fernández-Reyes; Diego Vicente; María Gomariz; Olatz Esnal; Joseba Landa; Eider Oñate; Emilio Pérez-Trallero
Journal:  Antimicrob Agents Chemother       Date:  2014-01-06       Impact factor: 5.191

5.  Involvement of virulence properties and antibiotic resistance in Escherichia coli strains causing pyelonephritis in children.

Authors:  Ján Koreň; Katarína Čurová; Marta Kmeťová; Leonard Siegfried; Viktor Jankó; László Kovács; Helena Hupková; Ján Luha
Journal:  Folia Microbiol (Praha)       Date:  2012-06-21       Impact factor: 2.099

6.  Lost without Occam's razor: Escherichia coli tricuspid valve endocarditis in a non-intravenous drug user.

Authors:  Jo-Ai Foley; Daniel Augustine; Richard Bond; Kate Boyce; David Maciver
Journal:  BMJ Case Rep       Date:  2010-08-10

7.  Characterization of the contribution to virulence of three large plasmids of avian pathogenic Escherichia coli chi7122 (O78:K80:H9).

Authors:  Melha Mellata; Keith Ameiss; Hua Mo; Roy Curtiss
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

8.  Characterization of Ciprofloxacin-Resistant and Ciprofloxacin-Susceptible Uropathogenic Escherichia coli Obtained from Patients with Gynecological Cancer.

Authors:  Muniqui S Capett; Patricia Vollú-Silva; Vanessa A Melchiades; Luciana C Bokehi; Fernanda M Araújo; Ianick Souto Martins; Felipe P G Neves; Alice G M Gonzalez; Eric Oswald; Geraldo R de Paula; Lenise A Teixeira
Journal:  Curr Microbiol       Date:  2016-07-26       Impact factor: 2.188

9.  Genetic relatedness and virulence gene profiles of Escherichia coli strains isolated from septicaemic and uroseptic patients.

Authors:  N L Ramos; M L Saayman; T A Chapman; J R Tucker; H V Smith; J Faoagali; J C Chin; A Brauner; M Katouli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-09-08       Impact factor: 3.267

10.  The emergence and dissemination of CTX-M-producing Escherichia coli sequence type 131 causing community-onset bacteremia in Israel.

Authors:  D Karfunkel; Y Carmeli; I Chmelnitsky; T Kotlovsky; S Navon-Venezia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-11-02       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.